Terso Solutions and Medical Tracking Solutions Partner to Launch RFID Surgical Loaner Kit Tracking Solution

Terso Solutions announced today its partnership with Medical Tracking Solutions, Inc. (MTS), developer of the inventory management software iTraycer. Together, Terso and MTS will launch an RFID surgical loaner kit tracking solution to enable visibility for manufacturers and hospitals from warehouse to point of use and everything in between.

Visibility of any inventory type is essential to manufacturers and hospitals. However, that necessity, along with the level of difficulty, significantly increases when it comes to surgical loaner kits. One surgical loaner kit can contain a multitude of items and will be transferred to multiple locations prior to reaching its destination in a hospital OR. The Terso + MTS pre-integrated RFID enabled surgical loaner kit tracking solution will allow for visibility of both the kit’s location and contents, saving manufacturing and hospital personnel valuable money and time.

“The combination of RFID hardware with inventory management software is not a novel idea,” said Jonathan Tillman, CEO of MTS. “What is novel is having a pre-integrated, off the shelf solution, using the best in class hardware and software technologies. This solution speeds deployment and significantly reduces the cost to bring loaner operations into the 21st century.”

Both Terso and MTS anticipate this partnership having a positive impact on the medical device management landscape, as the RFID surgical loaner kit tracking solution allows for an ease of integration previously not believed possible.

“Our partnership with MTS adds the critical workflow of loaner kit processing and management to the portfolio of solutions we are offering to medical device manufactures,” said Joe Pleshek, CEO & President of Terso, “Our goal is to help our customers build an integrated inventory management platform that provides real time visibility of medical devices from the point of product manufacturer to the point of consumption within hospitals. iTraycer software integrated with UHF RFID devices from Terso automates loaner processing, saving time and lowering working capital needs.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”